The acquisition will strengthen Aventis Pharma’s business in India and allow the company to create a consumer healthcare and wellness platform in the country.
Universal Medicare is a manufacturer, marketer and distributor of branded nutraceutical formulations in India through their sales and marketing infrastructure.
Sanofi South Asia vice president and Aventis Pharma managing director Shailesh Ayyangar said said this strategic acquisition will allow Aventis Pharma and Sanofi Group to reach out to large sections of India’s population through a broad offering comprising of pharmaceuticals, vaccines and now nutraceuticals.